Ross Osborn

Stock Analyst at Cantor Fitzgerald

(0.6)
# 2600
Out of 5,441 analysts
126
Total ratings
Success rate
Average return
25 Stocks
Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Overweight
7 9
4.61 95.23% 4 Aug 8, 2025
LMAT LeMaitre Vascular
Maintains: Neutral
92 95
92.59 2.6% 2 Aug 6, 2025
CVRX CVRx
Reiterates: Overweight
11 11
7.51 46.47% 3 Aug 5, 2025
SIBN SI-BONE
Reiterates: Overweight
25 25
15.39 62.44% 10 Aug 5, 2025
MDXG MiMedx Group
Maintains: Overweight
11 12
7.05 70.21% 5 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
12
6.92 73.41% 1 Jul 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 7
9.38 -25.37% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
2 2
1 100% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
17 17
8.86 91.87% 6 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
12 9
4.71 91.08% 11 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
46 46
26.84 71.39% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8 8
1.97 306.09% 10 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
24 24
14 71.43% 3 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.25 220% 4 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
9 9
8 12.5% 7 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
3.51 156.41% 1 Jan 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
21 21
4.8 337.5% 10 Dec 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
16 16
6.97 129.56% 4 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.25 180% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
0.62 303.23% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
4 4
n/a n/a 5 Apr 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9
n/a n/a 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 21
9.54 120.13% 2 Apr 22, 2022